PDF(1413 KB)
Clinical features of children with immunodeficiency and Mycobacterium tuberculosis infection
WANG Wen-Ping, LIU Quan-Bo
Chinese Journal of Contemporary Pediatrics ›› 2020, Vol. 22 ›› Issue (12) : 1300-1305.
PDF(1413 KB)
PDF(1413 KB)
Clinical features of children with immunodeficiency and Mycobacterium tuberculosis infection
Objective To study the clinical features of Mycobacterium tuberculosis infection in children with secondary immunodeficiency disease (SID) versus primary immunodeficiency disease (PID). Methods A retrospective analysis was performed on the medical data of children with immunodeficiency and Mycobacterium tuberculosis infection (36 children with SID and 52 with PID) and 108 children with Mycobacterium tuberculosis infection but without immunodeficiency (control group). Results The onset age in the PID group was significantly lower than those in the control and SID groups (P < 0.05), and the proportation of males in the PID group was significantly higher than those in the control and SID groups (P < 0.05). Compared with the control group, the SID and PID groups had significantly lower incidence rates of tuberculosis poisoning symptoms (night sweeting, weight loss, fatigue and loss of appetite) and positive rate of PPD test (P < 0.05), as well as a significantly higher incidence rate of the involvement of ≥ 3 pulmonary lobes (P < 0.05). The children with PID tended to have the involvement of multiple organs (P < 0.05). The SID group had a significantly higher incidence rate of miliary shadow on chest CT than the control and PID groups (P < 0.05). The PID group had a significantly lower positive rate of IFN-gamma release assay (IGRA) than the control and SID groups (P < 0.05). Mycobacterium tuberculosis infection manifested as latent tuberculosis infection (36.1%) and active tuberculosis (63.9%) in the SID group. The infection mainly manifested as bacille Calmette-Guérin disease in the PID group (90.4%), among whom 2 children (3.8%) also had tuberculosis. Conclusions Children with immunodeficiency and Mycobacterium tuberculosis infection have atypical clinical symptoms, with a high incidence rate of disseminated infection and low positive rates of PPD and IGRA tests, which may lead to misdiagnosis and missed diagnosis. Children with immunodeficiency should undergo regular tuberculosis screening for early identification and intervention.
Primary immunodeficiency / Secondary immunodeficiency / Mycobacterium tuberculosis infection / Clinical feature / Child
[1] Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17):2747-2771.
[2] Bell DM, Morens DM, Holman RC, et al. Kawasaki syndrome in the United States 1976 to 1980[J]. Am J Dis Child, 1983, 137(3):211-214.
[3] 付培培, 杜忠东, 潘岳松. 2002-2010年北京儿童医院川崎病住院患儿临床分析[J]. 实用儿科临床杂志, 2012, 27(9):661-664.
[4] 王宏伟, 程佩萱. 川崎病再发10例临床分析及文献复习[J]. 中国实用儿科杂志, 2003, 18(2):96-98.
[5] 孔东明, 邓淑珍, 王瑞耕, 等. 川崎病再发22例[J]. 实用儿科临床杂志, 2012, 27(21):1668-1669.
[6] 姚晓利, 张静. 儿童再发川崎病77例临床特征回顾性分析[J]. 中国循证儿科杂志, 2013, 8(6):442-446.
[7] 刘仕成, 朴金花, 韩燕燕. 再发川崎病13例临床分析[J]. 中华临床医师杂志(电子版), 2010, 4(7):1123-1124.
[8] 邹丽霞, 龚方戚. 再发川崎病20例临床分析[J]. 中国当代儿科杂志, 2008, 10(5):617-619.
[9] 王珍全, 金佳蕙, 荣星, 等. 再发川崎病17例临床分析[J]. 浙江临床医学, 2014, 16(8):1279-1280.
[10] Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors[J]. Eur J Pediatr, 2013, 172(12):1641-1647.
[11] 王芳洁, 孙力安, 冯迎军. 川崎病再发9例[J]. 中外健康文摘, 2013(39):80-82.
[12] Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan:results of the 2009-2010 nationwide survey[J]. J Epidemiol, 2012, 22(3):216-221.
[13] McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease:a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17):e927-e999.
[14] Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease[J]. J Pediatr, 2008, 153(1):117-121.
[15] Kobayashi T, Fuse S, Sakamoto N, et al. A new Z score curve of the coronary arterial internal diameter using the Lambda-Mu-Sigma method in a pediatric population[J]. J Am Soc Echocardiogr, 2016, 29(8):794-801.e29.
[16] Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[EB/OL].[2020-04-10]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
[17] Chahal N, Somji Z, Manlhiot C, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada[J]. Pediatr Int, 2012, 54(3):383-387.
[18] Maddox RA, Holman RC, Uehara R, et al. Recurrent Kawasaki disease:USA and Japan[J]. Pediatr Int, 2015, 57(6):1116-1120.
[19] de La Harpe M, di Bernardo S, Hofer M, et al. Thirty years of Kawasaki disease:a single-center study at the University Hospital of Lausanne[J]. Front Pediatr, 2019, 7:11.
[20] Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan:results of the 2007-2008 nationwide survey[J]. J Epidemiol, 2010, 20(4):302-307.
[21] Kim GB, Park S, Eun LY, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014[J]. Pediatr Infect Dis J, 2017, 36(5):482-485.
[22] Sudo D, Nakamura Y. Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years[J]. Acta Paediatr, 2017, 106(5):796-800.
[23] 李菲, 周娟, 丁媛, 等. 单中心6年川崎病住院患儿早期并发冠状动脉瘤危险因素分析[J]. 中华实用儿科临床杂志, 2019, 34(9):680-683.
[24] Sharma SD, Chaturvedi K, Saini A, et al. Recurrence of coronary artery lesions after complete regression in a peculiar case of Kawasaki disease[J]. Cardiol Young, 2019, 29(5):714-716.
